Citation Impact
Citing Papers
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
1992
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
Long-term outcome following successful reopening of abrupt closure after coronary angioplasty
1993
Noninvasive assessment of left ventricular diastolic function by pulsed doppler echocardiography in patients with hypertrophic cardiomyopathy
1987
Prediction of coronary artery disease in patients undergoing operations for mitral valve degeneration
2001
Mechanisms of exercise limitation in hypertrophic cardiomyopathy
1992
Pathogenetic Mechanisms of Septic Shock
1993 Standout
Effects of Diltiazem on Left Ventricular Systolic and Diastolic Function in Hypertrophic Cardiomyopathy**This study was supported in part by Grant 18/1/57 1994–1995 from the Italian Ministry of University and Scientific Research (MURST 60%), Rome, Italy.
1996
The Systemic Amyloidoses
1997 Standout
Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation
2008
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Valvular Heart Disease
1997
A multicentre evaluation of the safety of intracoronary optical coherence tomography
2009
Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis
1994
Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy
1989
Disopyramide in hypertrophic cardiomyopathy II. Noninvasive assessment after oral administration
1988
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
2008
Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
1996
Unstable angina: Pathogenesis, diagnosis, and treatment
1993
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Predicting vascular complications in percutaneous coronary interventions
2003
The Failing Heart — An Engine Out of Fuel
2007 Standout
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
2003
The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
2000 Standout
Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience
2007
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy
2005
Differences in the Use of Procedures between Women and Men Hospitalized for Coronary Heart Disease
1991
Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty
1994
Aggressive Plaque Modification with Rotational Atherectomy and/or Cutting Balloon before Drug‐Eluting Stent Implantation for the Treatment of Calcified Coronary Lesions
2010
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Characteristics of cerebrovascular accidents after percutaneous coronary interventions
2004
Clinical and lesion morphologic determinants of coronary angioplasty success and complications: Current experience
1995
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
2012
Determinants of exercise capacity in hypertrophic cardiomyopathy
1989
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
1989
Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial
1998
Enhanced Detection of Ischemic but Viable Myocardium by the Reinjection of Thallium after Stress-Redistribution Imaging
1990
The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization
1999 Standout
ELOVL3 Is an Important Component for Early Onset of Lipid Recruitment in Brown Adipose Tissue
2005 StandoutNobel
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
1995
Aortic Regurgitation With Markedly Reduced Left Ventricular Function Is Not a Contraindication for Aortic Valve Replacement
2016
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions
1997
Does the AHA/ACC task force grading system predict outcome in multivessel coronary angioplasty?
1992
Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration
1988
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries
2003
Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: A change in the measuring stick
1987
A word of caution on optimizing stent deployment in calcified lesions: Acute coronary rupture with cardiac tamponade
1996
Chronic Aortic Regurgitation: Indications for Operation—1988
1988
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty
1997
Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy
2009
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Thyroid Hormone and the Cardiovascular System
2001 Standout
Endovascular stents: Preliminary clinical results and future developments
1993
Mortality Differences Between Men and Women After Percutaneous Coronary Interventions
2008
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Cardiovascular Health and Disease in Women
1993
Referral Patterns for Coronary Artery Disease Treatment: Gender Bias or Good Clinical Judgment?
1992
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Surgical management of hypertrophic obstructive cardiomyopathy
1995
Coronary Artery Stents
2000
Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?
2004
Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy
1992
Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
2008
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
1995
Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy
1993
Hypertrophic cardiomyopathy
1994
Comparison of the Effects of Nicorandil Versus Verapamil on the Incidence of Slow Flow/No Reflow During Rotational Atherectomy
2006
Therapeutic dissection after successful coronary balloon angioplasty: No influence on restenosis or on clinical outcome in 693 patients
1992
Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy
1990
Prevention of Contrast Media–Associated Nephropathy
2002
Review of Noninvasive Imaging for Hypertrophic Cardiac Syndromes and Restrictive Physiology
2006
Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions
2004
Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy
1994
Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis
1991
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology
1998
Prospects for the use of antagonists to the platelet glycoprotein IIb/ IIIa receptor to prevent postangioplasty restenosis and thrombosis
1991
Natural History and Left Ventricular Response in Chronic Aortic Regurgitation
1996
Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile
1992
Clinical outcome of severe asymptomatic chronic aortic regurgitation: A long-term prospective follow-up study
1995
Left ventricular systolic function in aortic stenosis
1988
Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study
1990
The case for surgery in obstructive hypertrophic cardiomyopathy
2004
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
1996
Managing Asymptomatic Patients With Chronic Aortic Regurgitation
1997
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy
1992
Stents in Total Occlusion for restenosis Prevention. The multicentre randomized STOP study
2000
Hypertrophic Cardiomyopathy
2002 Standout
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
1990 Standout
Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice
1995
Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
1999
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-The baylor experience (1996-2002)
2005
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy
1993
The Management of Hypertrophic Cardiomyopathy
1997
Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease
2005
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
1998
Re-Stenosis after Successful Coronary Angioplasty
1988
Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon Angioplasty
1998
Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone
1999
One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms
1999
Aortic regurgitation complicated by extreme left ventricular dilation: Long-term outcome after surgical correction
1996
A Comparison of Angioplasty with Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease
1992
A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy
1993
A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy
1989
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque
2001
Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions
2003
Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy
1994
Percutaneous Transluminal Coronary Angioplasty
1994
Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension
1989
Elastin is an essential determinant of arterial morphogenesis
1998 StandoutNature
Chronic Aortic Insufficiency: Factors Associated with Progression to Aortic Valve Replacement
1989
The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: Implications for revascularization in the transcatheter era
2014
Antithrombotic Therapy During Percutaneous Coronary Intervention
2004
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
2003 Standout
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy—A prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil
2007
Nicardipine and adenosine “flush cocktail” to prevent no-reflow during rotational atherectomy
2008
Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaques in the major epicardial coronary arteries at necropsy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and unstable angina pectoris
1989
Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients
1994
Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy
1996
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis
1988
Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
2002
Severe Aortic Stenosis and Coronary Artery Disease—Implications for Management in the Transcatheter Aortic Valve Replacement Era
2013
Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures
1992
Metabolic cardiomyopathies
2000
Long-Term Outcome of Surgically Treated Aortic Regurgitation
2006
Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology
2003
Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
1993
Myocarditis
2009 Standout
Acute hypothyroidism slows the rate of left ventricular diastolic relaxation
1989
The changing unnatural history of valvular regurgitation
1992
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques
1994
Hypertrophic Cardiomyopathy
1995
Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: Altered left ventricular loading or improved muscle inactivation?
1983
Paucity of subtle myocardial injury after angioplasty delineated with MB CK
1986
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
1983
Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.
1986
Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.
1983
Coronary Stenting After Rotational Atherectomy in Calcified and Complex Lesions
1997
Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy
1985
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
1985
The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty
1992
Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
2007
Effect of Thromboxane A 2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty
1995
Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function
2002
Relation between exercise-induced changes in ejection fraction and systolic loading conditions at rest in aortic regurgitation
1984
Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency
1984
Determinants of prognosis of patients with aortic regurgitation who undergo aortic valve replacement
1984
Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment.
1984
Five-Year Outcome in Patients With Isolated Proximal Left Anterior Descending Coronary Artery Stenosis Treated by Angioplasty or Left Internal Mammary Artery Grafting
1999
Diastolic filling dynamics in patients with aortic stenosis.
1986
DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
1996
Nonsurgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy
1997
Studies of controlled reperfusion after ischemia
1990
Hypertrophic cardiomyopathy: an important cause of sudden death.
1984
Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction.
1984
Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
1981
Preoperative left ventricular function: Minimal requirement for successful late results of valve replacement for aortic regurgitation
1987
Effect of Intracoronary Nicorandil Administration on Preventing No-Reflow/Slow Flow Phenomenon During Rotational Atherectomy
2002
ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Aortic valve replacement with coronary bypass grafting. Significant determinants of ten-year survival.
1983
Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: An intraoperative two-dimensional echocardiography study
1987
Current operative treatment of obstructive hypertrophic cardiomyopathy.
1988
Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency
1982
Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy
2007
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
1987
Early detection of left ventricular dysfunction in chronic aortic regurgitation as assessed by contrast angiography, echocardiography, and rest and exercise scintigraphy
1983
Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy
1986
Small intensely fluorescent cells in culture: role of glucocorticoids and growth factors in their development and interconversions with other neural crest derivatives
1985
Serial changes in left ventricular function after correction of chronic aortic regurgitation
1983
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
1981
The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function.
1983
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.
1988
Development and regression of left ventricular hypertrophy
1984
Aortic valve replacement with coronary bypass grafting
1983
NON‐SHIVERING THERMOGENESIS AND ITS THERMOREGULATORY SIGNIFICANCE
1973
Coronary artery disease and its management: Influence on survival in patients undergoing aortic valve replacement
1987
Afterload mismatch in aortic and mitral valve disease: Implications for surgical therapy
1985
Our Preoccupation With Coronary Luminology
1995
Tissue distribution of cold-induced thermogenesis in conscious warm- or cold-acclimated rats reevaluated from changes in tissue blood flow: The dominant role of brown adipose tissue in the replacement of shivering by nonshivering thermogenesis
1979
Combined valve replacement and myocardial revascularization
1984
Sex Bias in Considering Coronary Bypass Surgery
1987
Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy
1986
Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents
1985
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.
1986
Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions
1996
Prediction of Indications for Valve Replacement Among Asymptomatic or Minimally Symptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Performance
1998
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients.
1980
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
The cardiac patient and noncardiac surgery
1982
Postoperative regression of left ventricular dimensions in aortic insufficiency: A long-term echocardiographic study
1985
Intracoronary γ-Radiation Therapy After Angioplasty Inhibits Recurrence in Patients With In-Stent Restenosis
2000
A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids
1986 StandoutNobel
Endothelium-derived relaxing factor and coronary vasospasm.
1989
Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation
2000
Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy
1988
Molecular probes for the development and plasticity of neural crest derivatives
1985 StandoutNobel
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy
1984
Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy.
1980
Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy
1998
Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: Assessment with radionuclide cineangiography
1978
Primary isolated aortic valve replacement
1989
Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.
1985
Radionuclide angiographic exercise left ventricular performance in chronic aortic regurgitation: Relationship to resting echographic ventricular dimensions and systolic wall stress index
1982
Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial
1993
Causes of sudden death in competitive athletes
1986
Left ventricular function at rest and during exercise after aortic valve replacement in patients with aortic regurgitation
1979
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
2005
Aortic valve replacement associated with survival in severe regurgitation and low ejection fraction
2017
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis
1990
Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions
2002
Abnormal vasomotor changes early after coronary angioplasty. A quantitative arteriographic study of their time course.
1991
Early changes in left ventricular size and function after correction of left ventricular volume overload
1981
Muscular Subaortic Stenosis
1982
Cardiovascular response to dynamic exercise in patients with chronic symptomatic mild-to-moderate and severe aortic regurgitation.
1986
Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.
1981
Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
1991
One-Year Follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I)
1995
Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy.
1989
Randomized Comparison of Primary Stenting and Provisional Balloon Angioplasty Guided by Flow Velocity Measurement
2000
Progression of myocardial dysfunction in asymptomatic patients with severe aortic insufficiency
1986
Novel approach to the analysis of restenosis after the use of three new coronary devices
1992
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
1992
Mortality and Morbidity of Aortic Regurgitation in Clinical Practice
1999
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
1985
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
1986 Standout
Long Term Results and Predictors of Left Ventricular Function Recovery after Aortic Valve Replacement for Chronic Aortic Regurgitation
2015
Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
1987
Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.
1985
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study
1985
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
1985
Hypertrophic Cardiomyopathy
1987
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: Functional and morphologic features and clinical significance
1986
Reduction in sudden late death by concomitant revascularization with aortic valve replacement
1988
Chronic aortic regurgitation: Prognostic value of left ventricular end-systolic dimension and end-diastolic radius/thickness ratio
1983
Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.
1989
Relation Between Activated Clotting Time During Angioplasty and Abrupt Closure
1996
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary
2001
The Nerve Growth Factor 35 Years Later
1987 StandoutScienceNobel
Management of Symptoms in Hypertrophic Cardiomyopathy
2008
Estrogen Restores Endothelial Cell Function in an Experimental Model of Vascular Injury
1997
The Intima
1995
Aortic valve replacement combined with myocardial revascularization
1988
Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy
1987
Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy
1986
Chronic mitral regurgitation: Predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress
1984
Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation
1981
Sudden death in prinzmetal's angina with coronary spasm documented by angiography
1982
Randomized Comparison of Angioplasty of Complex Coronary Lesions at a Single Center
1997
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
2006
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Works of K.M. Kent being referenced
Regional contractility. Selective depression of ischemic myocardium by verapamil.
1976
Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic--histologic correlative analysis in 28 patients.
1981
The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit.
1993
Evaluating new devices. Acute (in-hospital) results from the New Approaches to Coronary Intervention Registry.
1994
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography.
1981
Mechanisms and results of additional stent implantation to treat focal in-stent restenosis
1998
Vascular complications after balloon and new device angioplasty.
1993
Histofluorescent Study of Catecholamine-Containing Elements in Cholinergic Ganglia from the Calf and Dog Lung
1973
Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry.
1993
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.
1979
One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry.
1989
Treatment of in-stent restenosis
2004
Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Assessment by radionuclide clineagiography in symptomatic and asymptomatic patients.
1978
Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.
1982
Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease.
1992
Morphological predictors of acute complications after percutaneous excimer laser coronary angioplasty. Results of a comprehensive angiographic analysis: importance of the eccentricity index.
1992
Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.
1978
Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry.
1985
Effect of septal myotomy and myectomy on left ventricular systolic function at rest and during exercise in patients with IHSS.
1979
Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients.
1980
Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.
1983
Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography.
1979
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.
1981
Aortic valve replacement without myocardial revascularization in patients with combined aortic valvular and coronary artery disease.
1981
Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
1983
Long-term hemodynamic assessment of the porcine heterograft in the mitral position. Late development of valvular stenosis.
1981
Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.
1994
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
1990
Improved left ventricular diastolic filling in patients with coronary artery disease after percutaneous transluminal coronary angioplasty.
1982
Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: reversal after coronary angioplasty.
1985
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
1979
Evaluation of aortic valve replacement in patients with valvular aortic stenosis.
1980
Effect of exercise and cold on cardiac output in warm- and cold-acclimated rats.
1969